Efficacy and safety of pasireotide-LAR for the treatment of refractory bleeding due to gastrointestinal angiodysplasias: results of the ANGIOPAS multicenter phase II noncomparative prospective double-blinded randomized study. (Q50301027)
Jump to navigation
Jump to search
scientific article published on 16 February 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of pasireotide-LAR for the treatment of refractory bleeding due to gastrointestinal angiodysplasias: results of the ANGIOPAS multicenter phase II noncomparative prospective double-blinded randomized study. |
scientific article published on 16 February 2018 |
Statements
1 reference
Efficacy and safety of pasireotide-LAR for the treatment of refractory bleeding due to gastrointestinal angiodysplasias: results of the ANGIOPAS multicenter phase II noncomparative prospective double-blinded randomized study. (English)
1 reference
Mourad Benallaoua
Jean-Christophe Saurin
Marouane Boubaya
Christophe Cellier
René Laugier
Magalie Vincent
Christian Boustière
Rodica Gincul
Elia Samaha
Philippe Grandval
Thomas Aparicio
Gheorghe Airinei
Bakhtiar Bejou
Cyriaque Bon
Jean-Jacques Raynaud
Denis Sautereau
16 February 2018
1 reference
1756283X18756260
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference